Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Profiteer who wrote (3060)	7/12/1998 7:35:00 PM
From: Prospector	Respond to of 5402

Dr. Thomas C. Drees M.B.A. PhD.. The company's founder and President, has been in the forefront of the artificial blood products for over twenty years. He was the President and CEO of Alpha Therapeutics, the only company to have abtained FDA approval of synthetic blood to date.. he brings to Sanguine many years of experience with the FDA approval process and all other aspects of the artificial blood industry. Dr Drees has written the extensively on the subject of artifical Blood. His publications include the book "Blood Plasma: The Promise and the Politics, published in 1983.